OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
First Short-Term Effectiveness and Security Data of Tralokinumab in Severe Atopic Dermatitis in Real Clinical Practice
Rubén García Castro, Felipe Heras Mendaza, Diana Inmaculada Santiago Sánchez-Mateos, et al.
Dermatitis (2023) Vol. 35, Iss. 3, pp. 301-303
Closed Access | Times Cited: 9
Rubén García Castro, Felipe Heras Mendaza, Diana Inmaculada Santiago Sánchez-Mateos, et al.
Dermatitis (2023) Vol. 35, Iss. 3, pp. 301-303
Closed Access | Times Cited: 9
Showing 9 citing articles:
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
Amalie Thorsti Møller Rønnstad, Christopher G. Bunick, Raj Chovatiya, et al.
American Journal of Clinical Dermatology (2025)
Closed Access | Times Cited: 1
Amalie Thorsti Møller Rønnstad, Christopher G. Bunick, Raj Chovatiya, et al.
American Journal of Clinical Dermatology (2025)
Closed Access | Times Cited: 1
Efficacy and safety of tralokinumab in the treatment of head and neck pattern atopic dermatitis: A multicentre study of 12 patients
F.J. Navarro‐Triviño, María Salazar‐Nievas, Juan Luís Sanz-Cabanillas, et al.
Australasian Journal of Dermatology (2024) Vol. 65, Iss. 3, pp. 260-265
Closed Access | Times Cited: 6
F.J. Navarro‐Triviño, María Salazar‐Nievas, Juan Luís Sanz-Cabanillas, et al.
Australasian Journal of Dermatology (2024) Vol. 65, Iss. 3, pp. 260-265
Closed Access | Times Cited: 6
Atopic Dermatitis in the Elderly Population
Martina Maurelli, Andrea Chiricozzi, Ketty Peris, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv13363-adv13363
Open Access | Times Cited: 14
Martina Maurelli, Andrea Chiricozzi, Ketty Peris, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv13363-adv13363
Open Access | Times Cited: 14
Effectiveness of Tralokinumab for Different Anatomical Sites and Clinical Signs in Atopic Dermatitis: A 36-Week Real-World Study
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2025)
Closed Access
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2025)
Closed Access
Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study
Laura Marina Calabrese, Élisa Cinotti, Martina D’Onghia, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv42275-adv42275
Open Access
Laura Marina Calabrese, Élisa Cinotti, Martina D’Onghia, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv42275-adv42275
Open Access
Predictive Factors for Poor Responders to Tralokinumab in Moderate-to-Severe Atopic Dermatitis: A Real-World Analysis
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2025)
Closed Access
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2025)
Closed Access
Identification of Early and Late Responders to Anti-IL-13 Antibody Tralokinumab in Atopic Dermatitis: A Real-World Japanese Study
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2024)
Closed Access | Times Cited: 2
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2024)
Closed Access | Times Cited: 2
A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults
Elena Pezzolo, Andrea Sechi, Jacopo Tartaglia, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 3, pp. 255-266
Closed Access | Times Cited: 2
Elena Pezzolo, Andrea Sechi, Jacopo Tartaglia, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 3, pp. 255-266
Closed Access | Times Cited: 2
Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28‐Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels
Coco Dekkers, Nicolaas P. A. Zuithoff, Daphne S. Bakker, et al.
Allergy (2024)
Closed Access
Coco Dekkers, Nicolaas P. A. Zuithoff, Daphne S. Bakker, et al.
Allergy (2024)
Closed Access
